4Bio Capital is an institutional investor (Conventional VCs) founded in 2014 and headquartered in London, United Kingdom. Venture capital investment firm. It is focused solely on the advanced therapies sector. It invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. It looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome.

Stage

seed, Series A, early-stage, seed, Series A, early-stage

Check size

$5M-$30M

AUM

~$200M+

HQ

London, United Kingdom

Founded

2014

Website

https://www.4biocapital.com/

LinkedIn

https://linkedin.com/company/4bio-capital

Twitter

http://twitter.com/4biocapital

What they look for

early-stage companies developing potentially curative treatments in areas of high unmet medical need; primarily UK, Europe, US; high-quality opportunities addressing technical gaps in biotech

Preparing to pitch 4Bio Capital?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.